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Abstract
Global transcriptional analyses have been performed with human embryonic stem cells
(hESC) derived cardiomyocytes (CMs) to identify molecules and pathways important for
human CM differentiation, but variations in culture and profiling conditions have led to great-
ly divergent results among different studies. Consensus investigation to identify genes and
gene sets enriched in multiple studies is important for revealing differential gene expression
intrinsic to human CM differentiation independent of the above variables, but reliable meth-
ods of conducting such comparison are lacking. We examined differential gene expression
between hESC and hESC-CMs from multiple microarray studies. For single gene analysis,
we identified genes that were expressed at increased levels in hESC-CMs in seven data-
sets and which have not been previously highlighted. For gene set analysis, we developed
a new algorithm, consensus comparative analysis (CSSCMP), capable of evaluating en-
richment of gene sets from heterogeneous data sources. Based on both theoretical analysis
and experimental validation, CSSCMP is more efficient and less susceptible to experimen-
tal variations than traditional methods. We applied CSSCMP to hESC-CMmicroarray data
and revealed novel gene set enrichment (e.g., glucocorticoid stimulus), and also identified
genes that might mediate this response. Our results provide important molecular informa-
tion intrinsic to hESC-CM differentiation. Data and Matlab codes can be downloaded from
S1 Data.
Introduction
Human embryonic stem cells (hESC) self-renew; their differentiation to the cardiac lineage
represents a potentially unlimited source of cardiomyocytes (CMs) for therapies and as experi-
mental models to investigate mechanisms involved in human cardiac development and for dis-
ease progression. A genome-wide characterization of the molecular phenotype of hESC-CMs is
important for these applications. Microarray experiments have been performed by various
groups and have shown that hESC-CMs expressed contractile genes, transcription factors, po-
tassium channels and Ca handling genes that are commonly found in the heart [1–7]. In spite
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of this, there is remarkable divergence among these studies. [4] evaluated their list of 1311
genes upregulated in CM with those presented by [1], and by [2] and showed that only 33
genes were shared by all three studies. This divergence may be attributed to a number of experi-
mental variables such as hESC strains, differentiation conditions, culture duration and micro-
array platform/thresholds used (Table 1). For instance, [3] and [2] generated CMs by non-
directed, spontaneous embryoid body formation without addition of growth factors, while [7]
performed stage-specific addition of growth factors including bFGF, BMP4, activin etc. to di-
rect cardiac differentiation. In addition, 4 different hESC lines were used in the 6 studies; it has
been shown that different hESC lines have predetermined preferences to become ventricular,
atrial and pacemaker CMs with different electrophysiological properties [8]. It is to be expected
that the variables described above would impact the transcriptome of CMs generated. A con-
sensus comparative analysis from multiple studies would thus be invaluable to distinguish be-
tween factors/pathways crucial for CM differentiation and those that are reflections of
experimental conditions.
Gene set analysis is more effective than single gene analysis in identifying consensus expres-
sion patterns across different data sets in general, and represents a recent and successful analy-
sis tool family commonly adopted in bioinformatics studies [9–12]. These tools usually adopt a
complete data matrix or a large ordered gene list as the input, and assess statistical significance
based on multiple random permutations. While some groups have made their data matrices
publicly available, most microarray papers involving hESC-CMs only provide lists of differen-
tially expressed genes [1, 2, 4]. It is therefore difficult to perform gene set comparison across
multiple studies using heterogeneous data sources (including both data matrices and lists of
differentially expressed genes). In view of these challenges, we devised a novel algorithm to
identify gene sets that are enriched in hESC-CMs relative to hESC in multiple studies. We
showed that our new algorithm has improved properties compared to traditional methods, and
we identified differential expression changes in gene sets that have not been
previously reported.
Contribution of this paper
We are the first to perform consensus comparative investigation of hESC-CMs to identify
genes/gene sets upregulated in hESC-CMs independent of experimental conditions. We have
identified novel enrichment of genes and gene sets in hESC-CMs, and our results provide valu-
able information about the molecular program that is active in hESC-CMs. The main computa-
tional contribution of our work is the proposal of a new gene set analysis method, i.e.,
consensus comparative analysis (CSSCMP), to identify commonly enriched gene sets across
multiple studies based on lists of differentially expressed genes (without data matrices). From
both theoretical analysis and experimental validation, we show that our CSSCMP method has
a number of desirable properties: (a) Capability to detect randomness in the input. (b) Im-
provement of efficiency through relaxing the condition of using a large number of random per-
mutations commonly adopted by traditional gene set based analysis methods [9]. (c)
Mitigation of the problem of gene set size dependence. (d) Integration of information from
multiple heterogeneous data sources for improved analysis.
Related work
Transcriptomic profiling studies have been performed to characterize hESC-CMs and to iden-
tify gene regulatory mechanisms that control the differentiation of hESCs into CMs [1–6]. [1]
assessed time-dependent gene expression patterns of hESCs differentiating towards CMs. [2]
then identified genes and pathways that were upregulated in hESC-CM clusters compared to
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undifferentiated hESCs. [3] and [4] used CMs of higher purities (30–40%,> 99% respectively)
to compare the transcriptome of CMs with hESC and fetal heart cells, while [7] compared ven-
tricular hESC-CMs with fetal and adult CMs of the same lineage. A later study by [5] focused
on the expression of ion channel and Ca2+-handling genes in hESC-CM clusters. Most of the
hESC-CM studies only provided lists of significantly differentially expressed genes [1, 2, 4],
rather than the complete gene expression datasets. [4] and Synnergren et al. examined genes
commonly upregulated in 2–4 studies, but gene set analysis has not been performed [13].
Gene set analysis methods are more effective in the search for consensus results than single
gene analysis methods [9–12]. These tools can roughly be divided into two categories: (1) mi-
croarray data based methods, which in general access the full data matrices. Representative ex-
amples include GSEA [9], SAFE [14], SAM-GS [15];(2) significant gene list based methods,
which utilize lists of significantly differentially expressed genes as input. Representative exam-
ples include DAVID [10], FuncAssociate [16], WebGestalt [17] and Bingo [18]. However, to
our best knowledge, there are no effective tools that can identify differentially expressed gene
sets from heterogeneous data sources which include a combination of full data matrices and
gene lists with different thresholds for fold changes (FC).
Materials and Methods
Materials
We collected data from microarray studies [1–5, 7] as shown in Table 1. The first six data sets
correspond to heterogeneous CM populations with different purity levels, while the last one [7]
consists of purified hESC-CMs of the ventricular lineage. In view of the diverse nature of the
data sets, our main focus is on non-lineage specific analysis of the gene expression patterns of
hESC-CMs, instead of those associated with any particular chamber-specific lineage. For sever-
al studies [1, 2, 4], only lists of differentially expressed genes were available, and the corre-
sponding methods and parameters adopted by the original authors are shown in the column
‘Method and Parameter’ in Table 1. For the other studies, FC thresholds were set to 2 in order
to provide a uniform basis for comparison. We extracted two related gene set collections,
named the general Homo sapiens gene sets on Biological Process (HSBP) and the subset from
the work of British Heart Foundation-University College London on Biological Process
(UCLBP), respectively, from the Gene Ontology and Gene Ontology Annotation databases, in
the well-known.gmt file format. HSBP groups genes based on general biological processes and
is most suitable for examining gene functions. UCLBP is composed of genes mainly related to
Table 1. Summary of related studies and filtered differential expression conditions.
Study Strain Differentiation Protocol Age Isolation % Yield Method and Parameter #Sig. Gene
[1] HES2 END2 co-culture, no FBS 12d Mechanical dissection Uncertain p < 0.01; FC2 2608
[2] SA002 Spontaneous EB formation < 22d Mechanical dissection Uncertain SAM, FDR < 0.04;FC5 530
[3] H9 Spontaneous EB formation 14d Percoll gradient 40–45% FC2 5504
[4] HES3 CM differentiation with transgenic line 21d Antibiotic selection > 99% FDR < 0.05; FC2 1311
[5] SA002 Spontaneous EB formation 21d Mechanical dissection Uncertain FC2 1781
[5] SA002 Spontaneous EB formation 49d Mechanical dissection Uncertain FC2 1883
[7] HES2 Directed differentiation with growth factor 21d Transduction and sorting > 99% FC2 2896
doi:10.1371/journal.pone.0125442.t001
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heart development. We used version 1.1.2681 of the file gene ontology.1.0.obo (Time stamp:
06:03:2012 19:30, downloaded from the GO official website at http://www.geneontology.org/
ontology/oboformat_1_0/gene ontology.1_0.obo). For the Homo Sapiens annotation file, we
used version 1.225 of the file gene_association.goa human (Time stamp: 06:03:2012, down-
loaded from the Gene Ontology Annotation (UniProt-GOA) Database at ftp://ftp.ebi.ac.uk/
pub/databases/GO/goa/HUMAN/gene association.goa human.gz). The UCLBP gene set collec-
tion is constructed based on the work of British Heart Foundation-University College London
(BHF-UCL) GO teams and their coworkers on the representation of heart development in GO
[19], which is accessed from the file ftp://ftp.ebi.ac.uk/pub/databases/GO/GOA/bhf-ucl/gen-
e_association.goa_bhf-ucl.gz. To use up-to-date gene ontology and annotation data, we con-
struct these two gene set collections using a similar method as is adopted for the GSEA official
MsigDB C5 gene sets (see http://www.broadinstitute.org/gsea/msigdb/collection_details.
jsp#C5). Specifically, only entries associated with the following evidence codes were included:
Inferred from Direct Assay (IDA), Inferred from Physical Interaction (IPI), Inferred from Mu-
tant Phenotype (IMP), Inferred from Genetic Interaction (IGI), Inferred from Expression Pat-
tern (IEP), Inferred from Sequence or Structural Similarity (ISS), and Traceable Author
Statement (TAS). We removed gene sets with more than 500 genes or fewer than 15, to exclude
very broad categories or very narrow ones, as suggested by the GSEA user guide [9]. Specifical-
ly, there are 1564 gene sets in the HSBP gene set collection and 966 ones in UCLBP. Note that
the HSBP gene set collection is more general since it is related to most of the Homo Sapiens bi-
ological processes. On the other hand, the UCLBP gene set collection focuses on heart develop-
ment [19] and therefore it is more specific than the former one. Through a closer inspection of
the two gene set collections, we find that there are 915 gene sets in common in both gene set
collections, and therefore UCLBP can roughly be viewed as a subset of HSBP.
Methods
Given D individual studies, we extracted a combined gene set ψC of all NC genes in the different
studies (The superscript is used to distinguish entities associated with the combined gene set
from those of a specific gene set). Specifically, we constructed a NC × D overall contingency ma-
trixM with entriesmij as follows:
½Mij ¼ mij ¼
1 if gene i is up regulated in study j;
0 otherwise:
ð1Þ
(
Given a speciﬁc gene set ψG with NG genes within the combined gene set ψC, we can extract the
corresponding contingency matrixMG from the overall contingency matrix. An intuitive meth-
od is to compute the counting score (CS) of the lower triangular entries of the matrix LG =
(MG)T MG (here the notation (MG)T refers to the transpose of the matrix (MG)) as follows
ScsðMGÞ ¼
XD
a¼1
Xa
b¼1
LGab ¼
XD
a¼1
Xa
b¼1
XNG
i¼1
mGiam
G
ib: ð2Þ
The counting score reﬂects both the co-association of different study pairs and the number of
up-regulated genes in each study. However, it is notable that it suffers from the problem of pro-
ducing non-zero values for random contingency matrices, and its dependence on the matrix
size, similar to problems well discussed for the Rand index [20] as a cluster validity measure
[21–24]. For the j-th study, the estimated probability of a gene to be up-regulated based on the
Consensus Comparative Analysis of hESC-CMs
PLOSONE | DOI:10.1371/journal.pone.0125442 May 4, 2015 4 / 24
overall contingency matrix can be computed as
p^j ¼
PNC
i¼1 mij
NC
: ð3Þ
Thus the expected value of CS corresponding to a NR × D random contingency matrixMR can
be computed as
S¼ E
XD
a¼1
Xa
b¼1
XNR
i¼1
ðmRiamRibÞ
" #
 NR
XD
a¼1
Xa
b¼1
p^Ra p^
R
b ; ð4Þ
where p^Ra , p^
R
b are estimated up-regulation probabilities based on the random contingency ma-
trix. The second step follows from the approximation of the expected value based on the esti-
mated probabilities when NR is large. We can observe from Eq (4) that the score value is not
zero, and is correlated to the size of the gene set NR. Motivated by the adjusted Rand index and
related clustering measures proposed in [21, 23], which expresses the modiﬁed measures in the
form of Scs
S
SmaxS, where Scs and Smax represent the original score and the maximum possible score
respectively, and S represents the expected score value for random inputs, we propose an im-
proved consensus comparative analysis (CSSCMP) score based on the contingency matrix. The
maximum score value corresponding to the contingency matrixMG can be readily found when
all the entries are ones, i.e., all the entries of the matrix (MG)T MG equal NG. Thus, the maxi-
mum score value is computed as
Smax ¼
XD
a¼1
Xa
b¼1
XNG
i¼1
mGiam
G
ib ¼
NGDðD 1Þ
2
: ð5Þ
Therefore, the consensus comparative analysis score can be computed as
SCSSCMPðMGÞ ¼
Scs  S
Smax  S
¼
XD
a¼1
Xa
b¼1
XNG
i¼1m
G
iam
G
ib  NG
XD
a¼1
Xa
b¼1p^ap^b
NGDðD 1Þ
2
 NG
XD
a¼1
Xa
b¼1p^ap^b
:
ð6Þ
Compared to conventional gene set analysis methods, such as GSEA [9], our proposed
CSSCMP method has a number of advantages in handling imperfect data prevalent in the stud-
ies of hESC-CMs: (1) CSSCMP only uses lists of signiﬁcantly differentially expressed genes,
thus it is readily applicable to the analysis of multiple studies since many studies only release
their signiﬁcant gene lists rather than the full microarray data; (2) CSSCMP does not require
performing multiple random permutation trials, which is commonly used in traditional meth-
ods. In general, these kinds of random permutation trials require signiﬁcant computation time
(e.g., 1000 trials are commonly used in GSEA). As a result, our method improves computation-
al efﬁciency; (3) The CSSCMP score value is close to zero with random input contingency ma-
trices, which allows our approach to distinguish meaningful inputs from trivial ones. (4)
CSSCMP is less sensitive to the size of gene sets, which is also an important concern in tradi-
tional gene set analysis methods. Veriﬁcations of the last two properties are presented as fol-
lows, and conﬁrmed in experiments using both simulated and real data.
Proposition: Detection of randomness. CSSCMP is close to zero for a random input con-
tingency matrix, and is less sensitive to the size of gene sets. The verification is straightforward.
For a NR × D random input contingency matrixMR, when the number of genes in the random
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gene set NR is large enough, we have
ScsscmpðMRÞ ¼
Scs  S
Smax  S
¼
XD
a¼1
Xa
b¼1
XNR
i¼1ðmRiamRibÞ  NR
XD
a¼1
Xa
b¼1p^
R
a p^
R
b
NRDðD 1Þ
2
 NR
XD
a¼1
Xa
b¼1 p^
R
a p^
R
b

XD
a¼1
Xa
b¼1p^
R
a p^
R
b 
XD
a¼1
Xa
b¼1p^
R
a p^
R
b
DðD 1Þ
2

XD
a¼1
Xa
b¼1 p^
R
a p^
R
b
¼ 0:
ð7Þ
The third step follows from the approximation of the expected value of CS based on the esti-
mated up-regulation probabilities when NR is large. Note that the result is less sensitive to the
size of gene set NR, since this factor is removed in the third step.
Results
Gene based consensus comparative analysis in hESC-CMs relative to
hESCs
We first examined genes commonly upregulated in multiple individual studies. A pyramid
chart for statistics of commonly enriched genes in hESC-CMs relative to hESCs in multiple
studies is shown in Fig 1. Only a small number (i.e., 53) of genes are enriched in all studies
while a large number (i.e., 9431) is found in at least one study. This implies that interpretation
of the results at the level of gene sets is important besides the identification of individual genes.
In this section we will focus on consensus comparative analysis in hESC-CMs relative to hESCs
based on individual genes. Gene set based consensus comparative analysis will be performed in
the following section.
Genes uniformly enriched in hESC-CMs relative to hESCs in all studies. We first fo-
cused on genes that were uniformly enriched in hESC-CMs relative to hESCs, as listed in
Table 2. Up-regulated genes included those known to be crucial for heart development/func-
tion such as transcription factors e.g., MEF2C and GATA4, contractile genes e.g., MYH7 and
TNNC1 etc., as well as ion transport genes e.g., ATP2A2 and PLN etc. Interestingly, as shown
in Table 3, 40% (22 out of 54) of our upregulated genes were not highlighted by the hESC-CM
microarray studies examined.
These genes were commonly upregulated in hESC-CMs independent of culture condition
and differentiation protocol, and are likely to be important for early human CM differentiation.
Of these, 6 genes show CM-specific expression and were 10-fold enriched in hESC-CMs rela-
tive to both undifferentiated hESC and mixed embryoid bodies culture [4]. This list included
transcripts which are known to be important in the heart and whose presence in hESC-CMs
has not been reported. JPN2 and RGS5 are such examples [25–27], and are likely to be impor-
tant for controlling calcium handling and cardiac repolarization in hESC-CMs. In addition, we
identified upregulation of genes with unknown roles in the heart, and they are MICAL2 and
CPNE5. Both genes are strongly upregulated in hESC-CMs e.g. MICAL2 expression is 36 and
22 fold higher in hESC-CMs compared to hESCs and embryoid bodies respectively. In addi-
tion, both genes were also enriched by more than 8 fold in human fetal and adult CMs relative
to hESCs and embryoid bodies. MICAL2 is a cytoskeletal protein involved in adhesion and
actin polymerization [28]. CPNE5 encodes a poorly characterized Ca binding membrane
Consensus Comparative Analysis of hESC-CMs
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protein [29]. It is unclear what roles they play in heart development and function and merits
further attention.
Statistics of literature-curated marker genes of important biological processes in multi-
ple studies. We next examined the enrichment of selected genes known to be important for
cardiac functions such as contractile genes, cardiac transcription factors, Ca2+ handling genes,
and ion channels, and found significant variation among individual studies, as shown in Fig 2.
Gene sets associated with heart development, contraction, Ca2+ handling were uniformly upre-
gulated in all studies examined, but the upregulation of genes within these gene sets were not
uniform. 6 of the 9 contractile genes studied were enriched in all of the studies. By contrast,
none of the ion channel genes were enriched in all seven studies. For instance, KCNE1 and
KCNQ1 were enriched in only 3 out of 7 studies. Thus, in order to observe the enrichment of
gene groups corresponding to different biological processes and functions, gene set analysis is
required as an important complementary approach besides individual gene analysis.
Enriched biological process categories for uniformly enriched genes in different num-
bers of studies. To further evaluate variability in gene- and gene-set based methods, we next
assessed the gene ontology affiliations of genes uniformly enriched in multiple studies. Specifi-
cally, we identified genes that were significantly enriched in CMs in at least 7, 6, 5 and 4 studies
respectively, and extracted their Gene Ontology annotation as shown in Fig 3. The top BP cate-
gories were development, morphogenesis, cell communication, metabolism, and signal trans-
duction. The GO enrichment pattern was largely conserved irrespective of the number of
Fig 1. Statistics of common genes in hESC-CMs relative to hESCs in multiple studies.
doi:10.1371/journal.pone.0125442.g001
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Table 2. Common genes uniformly overexpressed in hESC-CMs compared to hESCs in all studies.
GENE SYMBOL ENSEMBL GENE ID GENE NAME
MEF2C ENSG00000081189 myocyte enhancer factor 2C
APOBEC2 ENSG00000124701 apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 2
COL21A1 ENSG00000124749 collagen, type XXI, alpha 1
TNNC1 ENSG00000114854 troponin C type 1 (slow)
IL6ST ENSG00000134352 interleukin 6 signal transducer (gp130, oncostatin M receptor)
RRAD ENSG00000166592 Ras-related associated with diabetes
TTN ENSG00000155657 titin
SYNPO2L ENSG00000166317 synaptopodin 2-like
TGFB2 ENSG00000092969 transforming growth factor, beta 2
EDNRA ENSG00000151617 endothelin receptor type A
KIFAP3 ENSG00000075945 kinesin-associated protein 3
GATA4 ENSG00000136574 GATA binding protein 4
LMOD1 ENSG00000163431 leiomodin 1 (smooth muscle)
PPP1R14C ENSG00000198729 protein phosphatase 1, regulatory (inhibitor) subunit 14C
MB ENSG00000198125 myoglobin
ACTA2 ENSG00000107796 actin, alpha 2, smooth muscle, aorta
MICAL2 ENSG00000133816 microtubule associated monoxygenase, calponin and LIM domain containing 2
MYH7 ENSG00000092054 myosin, heavy chain 7, cardiac muscle, beta
ACTN2 ENSG00000077522 actinin, alpha 2
MYH6 ENSG00000197616 myosin, heavy chain 6, cardiac muscle, alpha
FLNC ENSG00000128591 ﬁlamin C, gamma (actin binding protein 280)
TNNT2 ENSG00000118194 troponin T type 2 (cardiac)
CLIC5 ENSG00000112782 chloride intracellular channel 5
HSPB7 ENSG00000173641 heat shock 27kDa protein family, member 7 (cardiovascular)
SMPX ENSG00000091482 small muscle protein, X-linked
CTSB ENSG00000164733 cathepsin B
HSPB3 ENSG00000169271 heat shock 27kDa protein 3
PRNP ENSG00000171867 prion protein
NPPA ENSG00000175206 natriuretic peptide precursor A
ZNF436 ENSG00000125945 zinc ﬁnger protein 436
MYL7 ENSG00000106631 myosin, light chain 7, regulatory
MYL4 ENSG00000198336 myosin, light chain 4, alkali; atrial, embryonic
MYL3 ENSG00000160808 myosin, light chain 3, alkali; ventricular, skeletal, slow
COL2A1 ENSG00000139219 collagen, type II, alpha 1
MEIS1 ENSG00000143995 Meis homeobox 1
MSX2 ENSG00000120149 msh homeobox 2
PPP1R3C ENSG00000119938 protein phosphatase 1, regulatory (inhibitor) subunit 3C
MEIS2 ENSG00000134138 Meis homeobox 2
AGT ENSG00000135744 angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
FBN2 ENSG00000138829 ﬁbrillin 2
HRC ENSG00000130528 histidine rich calcium binding protein
TBX3 ENSG00000135111 T-box 3
CRIP2 ENSG00000182809 cysteine-rich protein 2
CSRP3 ENSG00000129170 cysteine and glycine-rich protein 3 (cardiac LIM protein)
TNNI1 ENSG00000159173 troponin I type 1 (skeletal, slow)
RASSF5 ENSG00000136653 Ras association (RalGDS/AF-6) domain family member 5
CDKN1A ENSG00000124762 cyclin-dependent kinase inhibitor 1A (p21, Cip1)
(Continued)
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Table 2. (Continued)
GENE SYMBOL ENSEMBL GENE ID GENE NAME
ATP2A2 ENSG00000174437 ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
PKP2 ENSG00000057294 plakophilin 2
SVIL ENSG00000197321 supervillin
PLN ENSG00000198523 phospholamban
RGS5 ENSG00000143248 regulator of G-protein signaling 5
BMP5 ENSG00000112175 bone morphogenetic protein 5
TMOD1 ENSG00000136842 tropomodulin 1
doi:10.1371/journal.pone.0125442.t002
Table 3. Genes that are significantly upregulated for hESC-CMs in the seven data sets.Only genes that
have not been highlighted in the individual studies are shown. Genes that are enriched by more than 10-fold
in hESC-CMs relative to both hESC and hESC-derived embryoid bodies are shown in bold. Fold changes are
based on data from [4], who used purified CMs and who compared hESC-CM gene expression with both
hESC and hESC-derived embryoid bodies.
Genes Name CM/
ES
CM/
EB
JPH2 junctophilin 2 72 31
COL21A1 collagen, type XXI, alpha 1 47 2
IL6ST interleukin 6 signal transducer (gp130, oncostatin M receptor) 161 5
KIFAP3 kinesin-associated protein 3 10 3
LMOD1 leiomodin 1 (smooth muscle) 6 4
MICAL2 microtubule associated monoxygenase, calponin and LIM domain
containing 2
36 22
FLNC ﬁlamin C, gamma (actin binding protein 280) 5 3
CTSB cathepsin B 3 3
ZNF436 zinc ﬁnger protein 436 15 4
MEIS1 Meis homeobox 1 44 2
MSX2 msh homeobox 2 167 5
PPP1R3C protein phosphatase 1, regulatory (inhibitor) subunit 3C 23 10
MEIS2 Meis homeobox 2 44 2
AGT angiotensinogen (serpin peptidase inhibitor, clade A, member 8) 52 4
RASSF5 Ras association (RalGDS/AF-6) domain family member 5 31 6
CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 3 4
PKP2 plakophilin 2 16 5
SVIL supervillin 10 5
RGS5 regulator of G-protein signaling 5 95 11
doi:10.1371/journal.pone.0125442.t003
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studies used. This shows that gene set based analysis is less sensitive to variations in different
studies than gene based analysis. The results also confirmed that the 7 studies were
closely related.
Gene set based consensus comparative analysis on hESC-CMs
In this section, we verified the properties of our method on both simulated data and real data.
Then, we presented the results of CSSCMP on hESC-CMs.
Verification of the properties of consensus comparative analysis. We first investigated
our CSSCMP analysis method using random contingency matrices of 20 individual studies
with various gene set sizes. As shown in Fig 4A and 4B, the CS score heavily depended on gene
set sizes, while CSSCMP scores were consistently small and insensitive to the sizes. These ob-
servations suggested that CSSCMP was capable of detecting randomness and was more robust
against the effect of gene set sizes, both of which were in agreement with the proposition in
Eq (7).
We next studied the CSSCMP scores with two extracted gene set collections (UCLBP and
HSBP) on the hESC-CM data and on random data with different levels of variances. Specifical-
ly, we computed the CSSCMP scores with the hESC-CM data and random data with different
levels of variance respectively, and computed the mean values of the top 10%, 20%, 30%, 40%,
Fig 2. Enrichment of representative genes of biological processes closely associated with heart development and function.
doi:10.1371/journal.pone.0125442.g002
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and 50% ones. These results are shown in Fig 4C and 4D, respectively. We have observed from
the new experiments that both HSBP/UCLBP have much higher CSSCMP scores than those of
random data. For example, the mean CSSCMP values of the top 10% gene sets are 0.22 and
0.25 for HSBP and UCLBP respectively, compared to a value of 0.03 for the random data. In
general, the mean scores of random data with different levels of variance are close and signifi-
cantly smaller. These results suggest that our CSSCMP score can readily separate meaningful
data from random data, regardless of their variance. In addition, we ranked the gene sets in de-
scending order of the corresponding scores, and plotted the sizes of these gene sets, as shown
in Fig 5. For CS, top ranks were associated with high gene set sizes, while no such association
existed for CSSCMP. These observations confirmed that CSSCMP was insensitive to the size of
gene sets.
Fig 3. Enriched GO BP categories for uniformly enriched genes in different numbers of studies: (a) 7 studies, (b) 6 studies; (c) 5 studies; (d) 4
studies.
doi:10.1371/journal.pone.0125442.g003
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Gene set based consensus comparative analysis on hESC-CMs. Based on 7 datasets from
6 individual hESC-CM studies, we ordered the UCLBP and HSBP gene sets according to their
CSSCMP scores to assess enrichment of gene sets in hESC-CMs relative to hESCs. For compar-
ison, we also employed gene set enrichment analysis (GSEA) [9] on four studies with full data
matrices to identify significantly enriched gene sets for each individual study [3, 5, 7].
For the HSBP gene set collection, the top 100 enriched gene sets are listed in Table 4, and
details are provided in S1 and S2 Tables. Our CSSCMP method generated results largely con-
sistent with those of GSEA. For instance, the 17 gene sets with the top CSSCMP scores were
considered enriched in all four individual studies by GSEA (S1 Table). Conversely, none of the
gene sets with the lowest 267 CSSCMP scores (under 0.014989) were considered enriched by
GSEA in any of the four individual datasets (S2 Table). Moreover, gene sets with the largest
Fig 4. Verification of the properties of consensus comparative analysis compared with random data. (a) Plots of CS scores based on random
contingency matrices of 20 individual studies with various gene set sizes; (b) Plots of CS scores based on random contingency matrices of 20 individual
studies with various gene set sizes; (c) Mean of CSSCMP scores of top HSBP gene sets compared with the hESC-CM data and random data with different
levels of variance; (d) Mean of CSSCMP scores of top UCLBP gene sets compared with the hESC-CM data and random data with different levels of
variance. The CS score heavily depends on the gene set sizes, while CSSCMP scores are insensitive to the size of gene sets and consistently small under
random data with different levels of variance.
doi:10.1371/journal.pone.0125442.g004
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CSSCMP scores included those known to be important for cardiac differentiation and function,
e.g., ventricular-cardiac-muscle-tissue-morphogenesis (GO:0055010), myofibril-assembly
(GO:0030239) and cardiac- muscle-tissue-morphogenesis (GO:0055008). This indicated that a
number of gene sets were uniformly enriched in hESC-CMs relative to hESCs regardless of di-
verse experimental conditions, and our CSSCMP method generated results that were in accor-
dance to those generated by GSEA and were biologically relevant.
In addition, CSSCMP identified enrichment of potentially important gene sets that were not
detected by GSEA based on individual studies. Examples included positive-regulation-of-reac-
tive-oxygen-species-metabolic-process (GO:2000379) and response-to-glucocortic-stimulus
(GO:0051384) etc., as shown in Tables 5 and 6. Reactive oxygen species is important for cardiac
Fig 5. Plots of gene set sizes for two extracted gene set collections in descending order of different scores: (a)UCLBP:CS, (b)UCLBP:CSSCMP, (c)
HSBP:CS, (d)HSBP:CSSCMP. The CS score heavily depends on the gene set sizes, while CSSCMP scores are insensitive to the sizes.
doi:10.1371/journal.pone.0125442.g005
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Table 4. The top 100 enriched gene sets in the HSBP gene set collection identified by CSSCMP scores, with comparison to the GSEA results in
four studies: study S1:purified hESC-CM (14 days) [3], S2: hESC-CM cluster (21 days) [5], S3: hESC-CM cluster (49 days) [5], and S4: purified
hESC-derived ventricular (21 days) [7]. The ’1’s under the four studies mean that the corresponding gene sets are enriched, while ’0’s mean not enriched.
Gene set names are represented with GO term IDs. Details can be found in supplementary files.
Gene Set Name CSSCMP Score PValue S1 S2 S3 S4
GO:0055010 0.543383 8.65E-49 1 1 1 1
GO:0030239 0.489238 1.14E-38 1 1 1 1
GO:0055008 0.488207 4.81E-54 1 1 1 1
GO:0048644 0.468182 4.12E-54 1 1 1 1
GO:0060415 0.468182 5.10E-47 1 1 1 1
GO:0060047 0.456301 1.35E-29 1 1 1 1
GO:0006941 0.449198 1.63E-44 1 1 1 1
GO:0030049 0.430482 3.83E-51 1 1 1 1
GO:0033275 0.430482 2.31E-50 1 1 1 1
GO:0003208 0.421429 5.94E-48 1 1 1 1
GO:0031032 0.420956 1.74E-33 1 1 1 1
GO:0048738 0.415963 4.86E-61 1 1 1 1
GO:0055007 0.411474 6.82E-30 1 1 1 1
GO:0043462 0.391521 1.16E-25 1 1 1 1
GO:0035051 0.347174 3.50E-33 1 1 1 1
GO:0030048 0.338497 5.50E-39 1 1 1 1
GO:0055002 0.327973 3.91E-29 1 1 1 1
GO:0048146 0.320188 4.09E-19 0 0 0 1
GO:0060411 0.304546 8.66E-12 0 1 0 0
GO:0008016 0.304546 6.78E-31 1 1 1 1
GO:0060537 0.294946 1.36E-52 1 1 1 1
GO:0003281 0.290107 1.07E-11 1 0 0 1
GO:0055001 0.28667 3.03E-25 1 1 1 1
GO:0043588 0.285295 1.02E-10 0 1 1 0
GO:0003279 0.271798 1.26E-13 0 1 0 1
GO:0010574 0.269051 1.95E-10 1 1 1 1
GO:0048747 0.266043 2.92E-11 1 1 1 1
GO:0003007 0.261514 7.47E-37 1 1 1 1
GO:0032835 0.26123 2.16E-15 1 1 0 1
GO:0030198 0.260027 9.77E-22 1 1 1 1
GO:0043062 0.260027 3.02E-21 1 1 1 1
GO:0006942 0.258222 2.36E-10 0 1 1 1
GO:0007517 0.25773 3.50E-48 1 1 1 1
GO:0010718 0.257178 9.58E-11 0 1 1 1
GO:0006937 0.256946 4.92E-20 0 1 1 1
GO:0048546 0.254719 5.10E-09 0 0 0 0
GO:0045669 0.252507 1.00E-11 0 1 0 1
GO:2000379 0.251003 1.16E-10 0 0 0 1
GO:0006936 0.245563 4.83E-57 1 1 1 1
GO:0034446 0.237467 2.30E-07 0 0 0 0
GO:0045778 0.236426 7.10E-12 1 1 1 1
GO:0042698 0.233486 1.01E-07 1 0 0 1
GO:0048742 0.233316 1.12E-10 1 1 0 1
GO:0071277 0.229239 2.53E-08 0 0 0 1
GO:0001937 0.228681 1.93E-08 1 1 1 1
(Continued)
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Table 4. (Continued)
Gene Set Name CSSCMP Score PValue S1 S2 S3 S4
GO:0003012 0.228532 9.85E-50 1 1 1 1
GO:0061061 0.220708 8.53E-52 1 1 1 1
GO:0010717 0.220547 4.80E-11 0 1 0 1
GO:0051153 0.21591 2.33E-12 1 1 1 1
GO:0014910 0.214376 1.18E-06 0 1 1 1
GO:0051384 0.212651 5.75E-06 0 1 1 0
GO:0003143 0.212161 3.24E-08 1 1 1 1
GO:0030501 0.210805 7.57E-08 1 1 0 1
GO:0048566 0.209894 1.37E-06 0 0 0 0
GO:0048010 0.209683 1.72E-06 0 1 1 1
GO:0051592 0.209566 1.67E-14 0 1 1 1
GO:0007507 0.20728 4.53E-40 1 1 1 1
GO:0048706 0.205883 2.00E-09 0 1 1 0
GO:0048565 0.204852 1.39E-11 0 0 0 1
GO:0010595 0.202956 4.50E-11 0 0 0 1
GO:0048705 0.199867 5.69E-11 0 0 0 0
GO:0048145 0.197553 3.36E-11 0 0 0 1
GO:0042692 0.195463 7.82E-24 1 1 1 1
GO:0035050 0.194776 1.33E-07 0 1 0 1
GO:0010594 0.190132 3.85E-13 0 0 0 1
GO:0045884 0.190091 8.39E-05 0 1 0 0
GO:0071407 0.190091 6.78E-05 1 1 1 1
GO:0031960 0.18984 2.93E-05 0 1 1 0
GO:0060349 0.188785 3.62E-06 0 0 0 0
GO:0016202 0.188694 1.14E-10 0 1 0 1
GO:0001947 0.187835 3.93E-06 0 1 0 1
GO:0002576 0.185384 1.10E-19 1 1 1 1
GO:0003158 0.181819 3.36E-05 1 0 0 1
GO:0060485 0.181185 1.49E-12 0 0 0 1
GO:0002062 0.1801 1.28E-05 0 1 0 1
GO:0008015 0.18006 5.05E-25 1 1 1 1
GO:0030324 0.178811 2.94E-06 1 0 0 1
GO:0051279 0.178811 1.28E-04 0 0 0 1
GO:0071560 0.177386 6.37E-05 1 1 1 1
GO:0050880 0.177006 3.62E-04 0 0 0 1
GO:0010596 0.175803 1.53E-04 0 0 1 1
GO:0003073 0.175427 5.00E-07 1 1 1 0
GO:0001837 0.175134 4.00E-06 0 0 0 1
GO:0050680 0.174395 9.11E-10 0 0 0 1
GO:0030500 0.173797 5.93E-08 0 1 0 1
GO:0030323 0.173521 3.15E-06 1 0 0 1
GO:0051216 0.173308 5.39E-09 0 0 0 1
GO:0001936 0.173129 1.18E-10 0 1 1 1
GO:0061371 0.172795 2.47E-05 0 1 0 1
GO:0060348 0.170818 4.62E-07 0 0 0 0
GO:2000377 0.170762 4.32E-07 0 0 0 0
GO:0003151 0.169787 1.94E-05 0 0 0 0
(Continued)
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Table 4. (Continued)
Gene Set Name CSSCMP Score PValue S1 S2 S3 S4
GO:0001649 0.16738 4.68E-06 0 0 0 1
GO:0009887 0.166493 3.73E-40 1 1 1 1
GO:0050729 0.165622 1.88E-05 1 0 1 1
GO:0009187 0.165385 2.98E-08 0 1 1 1
GO:0030326 0.164233 4.52E-05 0 0 0 1
GO:0060688 0.164087 5.10E-04 0 0 0 0
GO:0006939 0.163509 2.56E-04 0 0 0 0
GO:0006970 0.163019 1.87E-03 0 0 0 0
doi:10.1371/journal.pone.0125442.t004
Table 5. Selected gene sets enriched in hESC-CMs relative to hESCs.CSSCMP score and PVal were calculated based on seven data sets. For compari-
son, GSEA results in four studies are shown: study S1:purified hESC-CM (14 days) [3], S2: hESC-CM cluster (21 days) [5], S3: hESC-CM cluster (49 days)
[5], and S4: purified hESC-derived ventricular (21 days) [7]. The ’1’s under the four studies mean that the corresponding gene sets are enriched, while ’0’s
mean not enriched. Details can be found in the supplementary files.
Gene Set Name Score PVal S1 S2 S3 S4
response-to-glucocorticoid-stimulus 0.21 5.7e-006 0 1 1 0
positive-regulation-of-reactive-oxygen-species-metabolic-process 0.25 1.2e-010 0 0 0 1
doi:10.1371/journal.pone.0125442.t005
Table 6. Genes affiliated with “response-to-glucocorticoid-stimulus”. Fold changes in all seven data sets are also shown. S1-4 are defined as in (A). S5:
hESC-CM cluster (12 days) [1], S6:hESC-CM cluster (within 22 days) [2], S7:purified hESC-CM (22 days) [4]. Non-significant changes are shown as ’0’.
TargetID S1 S2 S3 S4 S5 S6 S7
ADAM9 4.1 3.6 5.9 0 3.6 0 0
AQP1 12.0 11.4 14.2 2.7 10 42 0
CALCR 0 0 0 0 0 0 0
GHRHR 0 0 0 0 0 0 0
GOT1 0 2.7 3.8 3 0 0 2.8
IL10 0 0 0 0 0 0 0
IL1RN 0 0 0 0 0 0 0
IL6 0 0 2.4 3.9 0 0 0
ISL1 8.6 2.7 0 2.8 7.8 43 0
NR3C1 0 0 0 0 0 0 39.3
PDCD7 0 0 0 0 0 0 0
REST 0 0 0 0 0 0 0
SLIT2 21.3 6.2 9 2.8 0 0 0
SLIT3 16.1 11.4 13 33.5 12.6 39 0
TNF 0 0 0 2.2 0 0 0
UBE2L3 0 0 0 0 0 0 0
doi:10.1371/journal.pone.0125442.t006
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differentiation of hESCs [30] but surprisingly it was not considered enriched by GSEA in any
of the individual studies. Response-to-glucocorticoid- stimulus (GO:0051384) was enriched in
two out of four datasets, but its role in hESC cardiac differentiation is unclear and requires fur-
ther attention. Examination of genes associated with glucocorticoid-stimulus showed that
ADAM9, AQP1, GOT1, ISL1, SLIT2 and SLIT3 were significantly upregulated in more than 4
of the 7 datasets and may be responsible for mediating the effect of this stimulus. Moreover,
false positive results can arise from individual studies partly as a reflection of the specific condi-
tions used in the experiment, and may not represent the biological entities examined. For in-
stance, GSEA examination of the Cao et al. data set showed that genes involved in
complement-activation (GO:0006956) was very significantly enriched in hESC-CMs. However,
CSSCMP of four datasets showed that this gene set was only enriched in this single study, with
a CSSCMP rank of 1349 and score of 0.012251, which is non-significant. By considering multi-
ple datasets, false positives related to specific biological conditions may be reduced. More de-
tailed results of different ranking between CSSCMP and results on GSEA with individual
studies are listed in S3 Table.
To further compare the performance of CSSCMP and GSEA, we also identified unrelated
gene sets that bear no obvious relationship to heart development and function (e.g. skin devel-
opment, platelet degranulation) among the top gene sets identified by CSSCMP with those
identified by GSEA of four individual studies (see S4 Table). Fig 6 shows the number of unre-
lated gene sets among the top 40 ones in each study. CSSCMP identified the smallest number
of unrelated gene sets compared to GSEA of the individual studies. Importantly, these unrelat-
ed gene sets identified by GSEA reflect the purity and biological properties of the samples used
in the individual studies. The samples used in Cao et al. [3] (besides Poon et al. [7]) have the
highest purity and this study has a smaller number of unrelated gene sets than Jane et al. [5].
Poon et al. [7] used lentiviral selection to isolate hESC-VCMs, and consequently have a large
number of gene sets related to inflammation, such as positive-regulation-of-cytokine-produc-
tion(GO:0001819), among its top 40 gene sets. In conclusion, these show that our CSSCMP is
superior in its ability to avoid false positive gene sets and are less sensitive to
sample heterogeneity.
For the UCLBP gene set collection, the top 100 sets are listed in Table 7, and details are pro-
vided in S5 Table. Scores of the members of the whole gene set list are provided in S6 Table.
Analysis with the UCLBP generated similar results as the HSBP gene set collection. As shown
in Fig 7, a large proportion of the top gene sets were the same in both gene set collections, and
this proportion was significantly larger than the average ratio for the two complete gene set col-
lections (i.e., 915/1564, plotted as a horizontal line). Specifically, 9 of the top 10 gene sets for
two gene set collections were the same. This showed that most of the enriched gene sets of
HSBP came from UCLBP, which is highly related to biological processes associated with
heart development.
Discussion
Application of hESC-CM for drug discovery and transplantation requires a thorough molecu-
lar characterization of these cells, but this is compromised by variations in experimental condi-
tions among different studies. Conventional methods are unsuitable for consensus analysis of
hESC-CMmicroarray data. To bridge this gap, we propose a new consensus comparison analy-
sis approach, CSSCMP, and identified novel changes in genes and gene sets that occur in
hESC-CM irrespective of different experimental variables. Based on the consensus information
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of different individual studies, our proposed CSSCMP approach has a number of advantages:
(1) detection of randomness in the input; (2) improvement of efficiency; (3) mitigation of the
problem of gene set size dependence; and (4) integration of information from multiple hetero-
geneous data sources.
The current study points to a number of important future research directions from both
computational and biological perspectives. From a computational perspective, an interesting
improvement of the current approach is to replace the current binary matrix entries with real
values for each individual study. From a biological perspective, a potential extension of the
present work is to study the interaction between the identified gene sets and microRNAs.
Fig 6. Proportion of unrelated HSBP gene sets identified by CSSCMP and GSEAwith individual studies: S1:purified hESC-CM (14 days) [3], S2:
hESC-CM cluster (21 days) [5], S3: hESC-CM cluster (49 days) [5], and S4: purified hESC-derived ventricular (21 days) [7]. CSSCMP identified the
smallest proportion of unrelated gene sets.
doi:10.1371/journal.pone.0125442.g006
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Table 7. The top 100 enriched gene sets in the UCLBP gene set collection identified by CSSCMP scores, with comparison to the GSEA results in
four studies: study S1:purified hESC-CM (14 days) [3], S2: hESC-CM cluster (21 days) [5], S3: hESC-CM cluster (49 days) [5], and S4: purified
hESC-derived ventricular (21 days) [7]. The ’1’s under the four studies mean that the corresponding gene sets are enriched, while ’0’s mean not enriched.
Gene set names are represented with GO term IDs. Details can be found in supplementary files.
Gene Set Name CSSCMP Score PValue S1 S2 S3 S4
GO:0055010 0.537743 7.50E-28 1 1 1 1
GO:0055008 0.48029 1.85E-27 1 1 1 1
GO:0030239 0.47623 6.75E-19 1 1 1 1
GO:0031032 0.47623 1.51E-17 1 1 1 1
GO:0048644 0.459429 2.37E-28 1 1 1 1
GO:0060415 0.459429 9.70E-25 1 1 1 1
GO:0060047 0.449585 1.66E-15 1 1 1 1
GO:0006941 0.442395 4.89E-24 1 1 1 1
GO:0030049 0.429944 2.57E-27 1 1 1 1
GO:0033275 0.429944 2.64E-28 1 1 1 1
GO:0003208 0.424462 2.70E-23 1 1 1 1
GO:0055007 0.417154 6.84E-17 1 1 1 1
GO:0048738 0.412149 7.38E-31 1 1 1 1
GO:0030048 0.398017 4.71E-24 1 1 1 1
GO:0035051 0.35252 1.30E-16 1 1 1 1
GO:0032835 0.350363 8.60E-10 1 1 1 1
GO:0008016 0.340415 1.35E-19 1 1 1 1
GO:0048146 0.328322 2.83E-10 1 0 0 1
GO:0030198 0.314836 1.50E-12 1 1 1 1
GO:0043062 0.314836 7.10E-14 1 1 1 1
GO:0051592 0.298392 3.85E-11 0 1 1 1
GO:0060411 0.295956 4.71E-06 0 1 0 0
GO:0055001 0.290475 1.63E-11 1 1 1 1
GO:0060537 0.28917 8.08E-24 1 1 1 1
GO:0045669 0.278294 1.92E-06 0 1 1 1
GO:0048747 0.278294 2.18E-05 1 1 1 0
GO:2000379 0.271188 4.41E-06 0 0 0 1
GO:0045778 0.267497 1.57E-06 1 1 1 1
GO:0048742 0.267235 2.25E-06 1 1 1 1
GO:0006942 0.263389 1.16E-05 1 1 1 1
GO:0003007 0.260764 1.82E-17 1 1 1 1
GO:0006937 0.260726 1.21E-10 0 1 1 1
GO:0051153 0.260023 1.19E-07 1 1 1 1
GO:0003279 0.259192 2.01E-06 1 1 0 1
GO:0042698 0.254542 2.62E-04 1 1 0 1
GO:0007517 0.253239 6.71E-24 1 1 1 1
GO:0048706 0.250887 5.46E-05 0 1 1 1
GO:0006936 0.245804 1.19E-27 1 1 1 1
GO:0030029 0.236588 1.63E-16 1 1 1 1
GO:0048145 0.233876 2.57E-06 0 0 0 1
GO:0061061 0.231061 3.45E-25 1 1 1 1
GO:0030501 0.230693 1.91E-04 1 1 1 1
GO:0031589 0.22844 7.70E-07 1 1 1 1
GO:0030855 0.226668 5.74E-08 1 1 1 1
GO:0016202 0.224865 1.75E-06 0 1 1 1
(Continued)
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Table 7. (Continued)
Gene Set Name CSSCMP Score PValue S1 S2 S3 S4
GO:0003143 0.223481 1.10E-04 1 1 1 1
GO:0048705 0.222536 9.56E-06 0 0 0 0
GO:0002576 0.219484 1.70E-10 1 1 1 1
GO:0008544 0.218811 2.53E-07 1 1 1 1
GO:0051384 0.217999 1.79E-03 0 1 1 0
GO:0042692 0.21723 4.88E-12 1 1 1 1
GO:2000377 0.215751 9.23E-05 0 0 0 0
GO:0007507 0.21305 8.17E-18 1 1 1 1
GO:0048565 0.212823 3.06E-04 0 0 0 1
GO:0014910 0.212061 2.74E-03 0 1 1 1
GO:0035050 0.211023 3.76E-04 1 1 1 1
GO:0007160 0.208255 1.13E-04 1 1 1 1
GO:0009887 0.20782 2.23E-20 1 1 1 1
GO:0009888 0.202841 2.64E-28 1 1 1 1
GO:0010717 0.202718 7.85E-04 0 0 0 1
GO:0030326 0.201556 1.91E-03 0 0 0 1
GO:0010595 0.200789 8.13E-05 0 0 0 1
GO:0003073 0.198885 1.09E-03 1 1 1 1
GO:0001947 0.196074 2.69E-03 1 1 0 1
GO:0030324 0.194044 4.45E-03 1 0 0 0
GO:0003158 0.19379 1.09E-02 1 0 0 1
GO:0060485 0.192594 1.92E-05 0 1 0 1
GO:0051216 0.190452 9.34E-04 0 0 0 1
GO:0048010 0.188766 9.72E-03 0 1 1 1
GO:0060393 0.188766 8.48E-03 0 0 0 1
GO:0043009 0.185924 8.15E-06 0 1 1 1
GO:0030500 0.185634 1.53E-03 1 1 1 1
GO:0071241 0.185416 2.74E-03 0 1 1 0
GO:0030323 0.184535 7.77E-03 1 0 0 0
GO:0030036 0.184286 8.25E-07 1 1 1 1
GO:0008015 0.183776 1.40E-09 1 1 1 1
GO:0021537 0.183023 8.38E-04 1 1 1 1
GO:0006887 0.182786 1.68E-07 1 1 1 0
GO:0072073 0.182371 2.58E-02 0 0 0 0
GO:0001822 0.181863 7.88E-06 1 1 1 1
GO:0050777 0.181027 1.07E-02 1 1 1 1
GO:0007179 0.179464 8.63E-04 0 1 0 1
GO:0010594 0.178634 1.27E-04 0 0 0 1
GO:0003151 0.177803 7.45E-03 0 0 0 0
GO:0048592 0.177803 6.83E-03 1 1 1 0
GO:0061371 0.176933 8.52E-03 0 1 0 1
GO:0045667 0.175193 1.11E-03 0 1 0 1
GO:0042476 0.174149 1.26E-02 0 1 1 0
GO:0048598 0.173476 1.13E-06 0 0 0 1
GO:0060541 0.173453 1.25E-02 1 0 0 0
GO:0050680 0.171278 7.10E-03 0 0 0 1
GO:0000079 0.170359 7.84E-03 1 1 1 1
(Continued)
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Table 7. (Continued)
Gene Set Name CSSCMP Score PValue S1 S2 S3 S4
GO:0072001 0.170243 2.50E-05 1 1 1 1
GO:0035303 0.169498 1.11E-02 0 1 0 1
GO:0021953 0.169277 4.56E-02 0 1 1 0
GO:0030278 0.169006 1.52E-04 1 1 0 1
GO:0001654 0.168668 7.37E-04 1 1 0 1
GO:0048646 0.168465 1.11E-10 1 1 1 1
GO:0051924 0.167965 1.07E-04 1 1 1 1
GO:0048762 0.167885 2.07E-03 0 1 0 1
doi:10.1371/journal.pone.0125442.t007
Fig 7. Proportion of common top gene sets in both gene set collections with respect to those in HSBP. The average ratio for the two complete gene
set collections (915/1564) is plotted as a horizontal line.
doi:10.1371/journal.pone.0125442.g007
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